Verapamil 120mg tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Buy It Now

Active ingredient:

Verapamil hydrochloride

Available from:

Accord-UK Ltd

ATC code:

C08DA01

INN (International Name):

Verapamil hydrochloride

Dosage:

120mg

Pharmaceutical form:

Oral tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 02060200; GTIN: 5012617009777

Patient Information leaflet

                                350x210 Leaflet Reel Fed Profile Landscape (BST)
Dimensions:
Component:
Date Sent:
Technologist: TECHNICALLY APPROVED
Pharmacode:
JDE No.:
Verapamil BP Tablets
40, 80, 120, 160mg x 25, 56, 84 (UK)
350x210 (Reel Fed)
50995430
Leaflet for Blisters
5778
T. Hull
26/10/20
page 1
page 4
* Please note that ONLY Artwork Studio is permitted to make changes to
the above artwork.
No changes are permitted by any 3rd party other than added notes and
mark ups for required changes.
approved for print/date
PROOF ROUND
Technical
Approval
NON PRINTING COLOURS
COLOURS
DATE SENT:
DATE RECEIVED:
Item number:
ORIGINATOR:
ORIGINATION DATE:
REVISION DATE:
REVISED BY:
DIMENSIONS:
MIN BODY TEXT SIZE:
SUPPLIER:
1.
2.
3.
4.
5.
6.
1.
2.
3.
EU-Artwork-Support@accord-healthcare.com
VERAPAMIL ALL STRENGTHS 28, 56, 84 TABLETS PIL - UK
Black
Profile
BBBA9696
M.Doak
17/11/2020
23/12/2020
M.Doak
350 x 210mm
9 pt
Accord Barnstaple
N/A
N/A
2
Version 7
12.02.2020
German GTIN 14
(incorporating PZN):
N/A
Cartons and label leaflets only
(labels only when specified)
50995430 BBBA9696
VERAPAMIL 40MG, 80MG, 120MG
AND 160MG TABLETS
Package leaflet: Information for the patient
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU
START TAKING THIS MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it
again.
•
If you have any further questions, ask your
doctor or pharmacist.
•
This medicine has been prescribed for you
only. Do not pass it on to others. It may harm
them, even if their signs of illness are the
same as yours.
•
If you get any side effects, talk to your doctor
or pharmacist. This includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1 WHAT VERAPAMIL TABLETS ARE AND WHAT
THEY ARE USED FOR
2
WHAT YOU NEED TO KNOW BEFORE YOU
TAKE VERAPAMIL TABLETS
3
HOW TO TAKE VERAPAMIL TABLETS
4
POSSIBLE SIDE EFFECTS
5
HOW TO STORE VERAPAMIL TABLETS
6
CONTENTS OF THE PACK AND OTHER
INFORMATION
1 WHAT VERAPAMIL TABLETS ARE AND WHAT
THEY ARE USED FOR
Verapamil belongs t
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
VERAPAMIL TABLETS BP 120mg
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 120mg Verapamil Hydrochloride PhEur.
Excipient with known effect
Sunset yellow aluminium lake (E110)
For the full list of excipients, see section 6.1
3
PHARMACEUTICAL FORM
Yellow film-coated tablets.
Yellow, circular, biconvex film-coated tablets, impressed “C” on
one face and
the identifying letters “VT” on the reverse. Tablet diameter:
8.55-9.45mm.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
1) The management of mild to moderate hypertension and renal
hypertension,
used alone or in combination with other antihypertensive therapy (see
section
4.3 for warning regarding concomitant administration with
beta-blockers).
2) For the management and prophylaxis of angina pectoris (including
variant
angina).
3) The treatment and prophylaxis of paroxysmal supraventricular
tachycardia
and the reduction of the ventricular rate in atrial
fibrillation/flutter. Verapamil
should not be used for atrial fibrillation/flutter in patients with
Wolff-
Parkinson-White syndrome (see section 4.4).
_4.2 _
_POSOLOGY AND METHOD OF ADMINISTRATION _
Posology
_Adults: _
_Hypertension:_ 240mg verapamil daily. For patients new to verapamil
therapy,
the physician should consider halving the initial dose to 120mg. Most
patients
respond to 240mg daily given as a single dose. If control is not
achieved after
a period of at least one week, the dosage may be increased to a
maximum of
480mg (in divided doses of 240mg in the morning and 240mg in the
evening,
at an interval of about twelve hours). A further reduction in blood
pressure
may be acheived by combining verapamil with other antihypertensive
agents,
in particular diuretics. 120mg may be used for dose titration
purposes. _ _
_Angina pectoris:_ 120mg twice daily. A small number of patients
respond to a
lower dose and where indictaed, adjustment down to 120mg daily could
be
made. 120mg may be used for dose titration purposes.
_ 
                                
                                Read the complete document
                                
                            

Search alerts related to this product